⚠ Medical Disclaimer
This article is for informational purposes only and does not constitute medical advice. GLP-1 medications require a prescription from a qualified healthcare professional. Always consult your GP or prescriber before starting, changing, or stopping any medication. Biomarker testing services like Lola Health are not a substitute for clinical care.
Lola Health Review 2026: Biomarker Monitoring for GLP-1 Users
Most people on GLP-1 medications track their weight. Far fewer track what's actually happening inside — their HbA1c, liver enzymes, lipid panel, kidney function. That's a gap worth closing.
Lola Health is a UK-based biomarker testing service. They are not a prescriber, and they do not offer GLP-1 prescriptions. What they do is run detailed blood panels, give you the results, and help you understand what they mean. For anyone on semaglutide or tirzepatide long-term, that kind of regular visibility matters.
This review covers what Lola Health tests, how the service works, and which panels make sense for GLP-1 users specifically.
Why GLP-1 Users Need More Than a Scales
Weight is one metric. But GLP-1 medications affect multiple systems simultaneously, and weight alone tells you almost nothing about the metabolic changes happening underneath.
Research
STEP 1 (NEJM 2021)
Semaglutide 2.4mg produced 14.9% mean weight loss at 68 weeks, alongside significant improvements in HbA1c, lipids, and blood pressure — confirming GLP-1 effects extend well beyond body weight
View study →The things worth monitoring on GLP-1:
- HbA1c and fasting glucose — to confirm metabolic improvement and rule out hypoglycaemia in people already on diabetes medication
- Lipid panel — semaglutide improves LDL and triglycerides in most people, but not everyone; tracking this matters for cardiovascular risk
- Liver enzymes (ALT, AST) — GLP-1 receptor agonists improve non-alcoholic fatty liver disease in most patients, but baseline and follow-up ALT gives you something to compare
- Kidney function (eGFR, creatinine) — nausea-driven reduced fluid intake creates dehydration risk; kidney markers flag this early
- Thyroid (TSH) — baseline matters given the theoretical rodent data on thyroid C-cell tumours; human trials have not confirmed this, but monitoring provides reassurance
- Full blood count — caloric restriction can lead to nutritional deficiencies, particularly if protein and micronutrient intake drops with appetite
None of these require a hospital appointment. A private blood test service handles all of it.
Key Takeaway
What Lola Health Is
Lola Health is a health testing service, not a clinic or prescriber. They offer at-home blood test kits, phlebotomy appointments at partner clinics, and digital results delivered via their platform. Their focus is proactive health monitoring — the longevity testing market rather than the NHS episodic care model.
They are not a GLP-1 prescriber. If you need a prescription, you need a separate service. For a list of vetted UK prescribers, see /guides/best-glp1-prescriber-uk-2026.
Where Lola Health is relevant is the monitoring layer — before starting, at 3 months, at 6 months, and annually thereafter.
Lola Health Biomarker Testing
Comprehensive blood panels for proactive health monitoring. Includes HbA1c, lipids, liver function, kidney markers, thyroid and more. At-home kit or clinic appointment options.
View on Lola Health →What Lola Health Tests
Lola Health offers multiple panel tiers. The markers most relevant for GLP-1 users span several categories.
Metabolic markers
- HbA1c (glycated haemoglobin — the gold standard for 3-month glucose control)
- Fasting glucose
- Insulin and HOMA-IR (insulin resistance score)
Lipid panel
- Total cholesterol
- LDL cholesterol
- HDL cholesterol
- Triglycerides
- Non-HDL cholesterol
Liver function
- ALT (alanine aminotransferase)
- AST (aspartate aminotransferase)
- GGT (gamma-glutamyl transferase)
- Bilirubin
- Albumin
Kidney function
- eGFR (estimated glomerular filtration rate)
- Creatinine
- Urea
- Uric acid
Thyroid
- TSH (thyroid-stimulating hormone)
- Free T4
- Free T3 (on higher tier panels)
Full blood count
- Haemoglobin
- Red blood cell count
- White blood cell count
- Platelets
Inflammation markers
- CRP (C-reactive protein) — high-sensitivity
- HbA1c already serves as a metabolic inflammation proxy
Research
SURMOUNT-1 (NEJM 2022)
Tirzepatide 15mg produced 20.9% weight loss at 72 weeks with significant reductions in triglycerides, LDL, blood pressure, and HbA1c — confirming the metabolic breadth of GLP-1/GIP agonism
View study →The Longevity Angle
There is a growing body of people using GLP-1 medications not primarily for weight loss but as part of a broader longevity or metabolic health protocol. The SELECT trial data — which showed a 20% reduction in major adverse cardiovascular events with semaglutide — has accelerated this trend.
Research
SELECT Trial (NEJM 2023)
Semaglutide 2.4mg reduced major adverse cardiovascular events by 20% in people with established CVD but without diabetes (n=17,604) — the first GLP-1 cardiovascular outcomes trial in non-diabetic patients
View study →For this group, longitudinal biomarker tracking is the point. Not just "am I losing weight" but "is my metabolic age improving? Is my visceral fat reducing? Is my cardiovascular risk profile shifting?"
Lola Health's platform fits this use case well. Regular panels, stored digitally, allow you to track trends over time rather than just point-in-time snapshots.
How the Testing Process Works
Lola Health offers two collection methods:
At-home finger-prick kits — suitable for smaller panels. You collect the sample yourself and return it by post. Results typically arrive within a few days.
Phlebotomy appointments — for larger panels or venous blood draws, Lola Health partners with clinics. You book, attend, and results go direct to your Lola Health dashboard.
Results come with reference ranges and brief explanations. For anything flagged as outside normal range, the recommendation is to follow up with your GP or prescriber — Lola Health interprets results but does not provide clinical management.
Amy’s Take
I used a phlebotomy-based panel before starting my semaglutide course. Having baseline liver and kidney numbers meant I could actually tell whether anything changed at 3 months — rather than just assuming everything was fine. That comparison is the whole point of baseline testing.
Recommended Testing Schedule for GLP-1 Users
For a full breakdown of which markers to test and when, see /guides/glp1-blood-test-panel-uk and /guides/glp1-monitoring-bloodwork-uk.
The short version:
Before starting GLP-1: Full metabolic panel — HbA1c, lipids, liver, kidney, thyroid, FBC. This is your baseline. Everything that follows is compared to this.
At 3 months: HbA1c, fasting glucose, kidney function. If nausea has been significant, hydration markers matter.
At 6 months: Full panel repeat. By this point, the metabolic effects of GLP-1 should be visible in your lipids and liver enzymes. Compare directly to baseline.
Annually thereafter: Full panel. If you are using GLP-1 long-term (as the evidence increasingly supports), annual comprehensive monitoring is standard practice.
Who Lola Health Is For
Lola Health suits GLP-1 users who:
- Want structured monitoring beyond what NHS appointments provide
- Are paying privately for GLP-1 and want to maximise the value of that investment
- Are interested in longitudinal health data — tracking trends rather than one-off results
- Have been told by their prescriber to monitor specific markers and want a convenient way to do so
It is not a replacement for NHS monitoring if your prescriber already runs these panels. It is a supplement for people whose monitoring is otherwise ad hoc or non-existent.
Pricing
Lola Health panel pricing varies by tier. At the time of writing, panels relevant to GLP-1 monitoring range from around £50 for targeted panels to £150–250 for comprehensive longevity-style testing. Check the current pricing on their site before ordering, as panels and prices are updated periodically.
The cost comparison that matters: a single comprehensive private blood test through Lola Health costs less than one month of most private GLP-1 prescriptions. Given that monitoring is what separates safe, effective long-term use from flying blind, it is a sensible addition to the overall cost.
Alternatives Worth Knowing
Lola Health is not the only option for private blood testing in the UK. Epic Life offers a mobile nurse model with AI coaching overlaid — useful if you prefer a home visit and want coaching on what the results mean. Medichecks and Forth are established alternatives with broad panel coverage.
The right choice depends on whether you want a basic testing service, a longevity-focused platform, or coaching alongside the data. For a direct comparison of testing services, see /guides/glp1-blood-test-panel-uk.
The Bottom Line
Lola Health is a competent, well-structured UK biomarker testing service. For GLP-1 users, the key panels cover exactly the markers that matter: metabolic health, liver function, kidney function, lipids, and thyroid.
The longevity framing of their platform matches how the most engaged GLP-1 users think about their medication — not as a short-term intervention but as part of a sustained metabolic health programme.
Use it to establish a baseline before you start, repeat at 3 and 6 months, and annually after that. The data you collect will be more useful to you and your GP than almost anything else you could track.